Latest Breaking News On - Cell engagers remain agents - Page 1 : comparemela.com

Expression of DLL3, an inhibitor ligand of the Notch pathway associated with tumorigenesis, has emerged as a target of interest for drug development.

United statesMartin wermkeUniversity hospital carl gustav carusAmerican society of clinical oncologyEarly clinical trial unitNational centerTumor diseases dresdenData emerges forNovel agentClinical oncologyAnnual meetingFall short targetingShows promiseCell engagers remain agentsPrecision med